http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 28 Jan 2026 09:00:19 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/ENvue+Medical+partners+with+U-Deliver+for+syringe+distribution/25904897.html <p>ENvue Medical Inc. (NASDAQ: FEED) announced a distribution agreement with U-Deliver to distribute its over-the-counter reusable ENFit Syringes nationwide through non-acute care channels, according to a press release statement.</p> <p>The partnership will utilize U-Deliver's digital and wholesale channels to expand access to ENvue's ENFit syringe product line across home and long-term care settings. ENvue Medical specializes in medical technology solutions for enteral care in clinical and home care environments.</p> <p>"We believe that our partnership with U-Deliver is an important step in scaling ENvue's over-the-counter ENFit syringe line and strengthening our presence in the non-acute enteral care market," said Doron Besser, Chief Executive http://www.streetinsider.com/Corporate+News/ENvue+Medical+partners+with+U-Deliver+for+syringe+distribution/25904897.html Wed, 28 Jan 2026 09:00:19 -0500 FEED NAOV http://www.streetinsider.com/Corporate+News/ENvue+Medical+partners+with+U-Deliver+for+syringe+distribution/25904897.html <p>ENvue Medical Inc. (NASDAQ: FEED) announced a distribution agreement with U-Deliver to distribute its over-the-counter reusable ENFit Syringes nationwide through non-acute care channels, according to a press release statement.</p> <p>The partnership will utilize U-Deliver's digital and wholesale channels to expand access to ENvue's ENFit syringe product line across home and long-term care settings. ENvue Medical specializes in medical technology solutions for enteral care in clinical and home care environments.</p> <p>"We believe that our partnership with U-Deliver is an important step in scaling ENvue's over-the-counter ENFit syringe line and strengthening our presence in the non-acute enteral care market," said Doron Besser, Chief Executive http://www.streetinsider.com/Corporate+News/ENvue+Medical+partners+with+U-Deliver+for+syringe+distribution/25904897.html Wed, 28 Jan 2026 09:00:19 -0500 FEED NAOV http://www.streetinsider.com/Press+Releases/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html <p><strong>Distribution agreement leverages U-Deliver’s digital and wholesale channels to expand access to ENvue’s recently launched ENFit Syringes across non-acute care channels</strong></p><p align="justify">TYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the signing of a distribution agreement with <a href="https://www.globenewswire.com/Tracker?data=STfEzTUOmGlg4u_dL-vpqGkgTIdxnFG7JBazVwKpMsKlNxsf7vPzQm2nDUe2n7cgkKsiRrJ2Cz3pIFy6-IsgxPkIt1XM-Jxn_I5O4l2jhoc=" rel="nofollow" target="_blank"><u>U-Deliver</u></a> to distribute ENvue’s recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels.</p> <p align="justify">“We believe that our http://www.streetinsider.com/Press+Releases/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html Wed, 28 Jan 2026 09:00:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Press+Releases/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html <p><strong>Distribution agreement leverages U-Deliver’s digital and wholesale channels to expand access to ENvue’s recently launched ENFit Syringes across non-acute care channels</strong></p><p align="justify">TYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the signing of a distribution agreement with <a href="https://www.globenewswire.com/Tracker?data=STfEzTUOmGlg4u_dL-vpqGkgTIdxnFG7JBazVwKpMsKlNxsf7vPzQm2nDUe2n7cgkKsiRrJ2Cz3pIFy6-IsgxPkIt1XM-Jxn_I5O4l2jhoc=" rel="nofollow" target="_blank"><u>U-Deliver</u></a> to distribute ENvue’s recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels.</p> <p align="justify">“We believe that our http://www.streetinsider.com/Press+Releases/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html Wed, 28 Jan 2026 09:00:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Press+Releases/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html <p><strong>Distribution agreement leverages U-Deliver’s digital and wholesale channels to expand access to ENvue’s recently launched ENFit Syringes across non-acute care channels</strong></p><p align="justify">TYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the signing of a distribution agreement with <a href="https://www.globenewswire.com/Tracker?data=STfEzTUOmGlg4u_dL-vpqGkgTIdxnFG7JBazVwKpMsKlNxsf7vPzQm2nDUe2n7cgkKsiRrJ2Cz3pIFy6-IsgxPkIt1XM-Jxn_I5O4l2jhoc=" rel="nofollow" target="_blank"><u>U-Deliver</u></a> to distribute ENvue’s recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels.</p> <p align="justify">“We believe that our http://www.streetinsider.com/Press+Releases/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html Wed, 28 Jan 2026 09:00:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html <p><strong>Distribution agreement leverages U-Deliver’s digital and wholesale channels to expand access to ENvue’s recently launched ENFit Syringes across non-acute care channels</strong></p><p align="justify">TYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the signing of a distribution agreement with <a href="https://www.globenewswire.com/Tracker?data=STfEzTUOmGlg4u_dL-vpqGkgTIdxnFG7JBazVwKpMsKlNxsf7vPzQm2nDUe2n7cgkKsiRrJ2Cz3pIFy6-IsgxPkIt1XM-Jxn_I5O4l2jhoc=" rel="nofollow" target="_blank"><u>U-Deliver</u></a> to distribute ENvue’s recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels.</p> <p align="justify">“We believe that our http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html Wed, 28 Jan 2026 09:00:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html <p><strong>Distribution agreement leverages U-Deliver’s digital and wholesale channels to expand access to ENvue’s recently launched ENFit Syringes across non-acute care channels</strong></p><p align="justify">TYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the signing of a distribution agreement with <a href="https://www.globenewswire.com/Tracker?data=STfEzTUOmGlg4u_dL-vpqGkgTIdxnFG7JBazVwKpMsKlNxsf7vPzQm2nDUe2n7cgkKsiRrJ2Cz3pIFy6-IsgxPkIt1XM-Jxn_I5O4l2jhoc=" rel="nofollow" target="_blank"><u>U-Deliver</u></a> to distribute ENvue’s recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels.</p> <p align="justify">“We believe that our http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html Wed, 28 Jan 2026 09:00:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html <p><strong>Distribution agreement leverages U-Deliver’s digital and wholesale channels to expand access to ENvue’s recently launched ENFit Syringes across non-acute care channels</strong></p><p align="justify">TYLER, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the signing of a distribution agreement with <a href="https://www.globenewswire.com/Tracker?data=STfEzTUOmGlg4u_dL-vpqGkgTIdxnFG7JBazVwKpMsKlNxsf7vPzQm2nDUe2n7cgkKsiRrJ2Cz3pIFy6-IsgxPkIt1XM-Jxn_I5O4l2jhoc=" rel="nofollow" target="_blank"><u>U-Deliver</u></a> to distribute ENvue’s recently launched over-the-counter reusable ENFit Syringes product line nationwide through non-acute care channels.</p> <p align="justify">“We believe that our http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Signs+Strategic+Partnership+Agreement+with+U-Deliver+for+U.S.+Distribution+of+Over-the-Counter+Reusable+ENFit+Syringe+Line/25904830.html Wed, 28 Jan 2026 09:00:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Management+Changes/ENvue+Medical+names+Marc+Waldman+as+VP+of+commercial+operations/25871739.html <p>ENvue Medical Inc. (NASDAQ: FEED) appointed Marc Waldman as Vice President, Commercial, the medical technology company announced. Waldman will lead the company's U.S. commercialization strategy and focus on expanding ENvue's presence beyond its current 38 hospital locations.</p> <p>Waldman brings over 35 years of medical device industry experience to the Tyler, Texas-based company. He previously served as North America Sales Director for the neonatal enteral feeding portfolio at NeoMed and later Avanos Medical following its acquisition. During his tenure there, he led revenue growth from approximately $39 million to $70 million over three and a half years.</p> <p>"Marc is a highly accomplished sales http://www.streetinsider.com/Management+Changes/ENvue+Medical+names+Marc+Waldman+as+VP+of+commercial+operations/25871739.html Wed, 21 Jan 2026 08:30:09 -0500 FEED NAOV http://www.streetinsider.com/Management+Changes/ENvue+Medical+names+Marc+Waldman+as+VP+of+commercial+operations/25871739.html <p>ENvue Medical Inc. (NASDAQ: FEED) appointed Marc Waldman as Vice President, Commercial, the medical technology company announced. Waldman will lead the company's U.S. commercialization strategy and focus on expanding ENvue's presence beyond its current 38 hospital locations.</p> <p>Waldman brings over 35 years of medical device industry experience to the Tyler, Texas-based company. He previously served as North America Sales Director for the neonatal enteral feeding portfolio at NeoMed and later Avanos Medical following its acquisition. During his tenure there, he led revenue growth from approximately $39 million to $70 million over three and a half years.</p> <p>"Marc is a highly accomplished sales http://www.streetinsider.com/Management+Changes/ENvue+Medical+names+Marc+Waldman+as+VP+of+commercial+operations/25871739.html Wed, 21 Jan 2026 08:30:09 -0500 FEED NAOV http://www.streetinsider.com/Press+Releases/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html <p><strong>Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growth</strong></p><p align="justify">TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue’s U.S. commercialization strategy, with a focus on expanding its existing presence in 38 http://www.streetinsider.com/Press+Releases/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html Wed, 21 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Press+Releases/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html <p><strong>Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growth</strong></p><p align="justify">TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue’s U.S. commercialization strategy, with a focus on expanding its existing presence in 38 http://www.streetinsider.com/Press+Releases/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html Wed, 21 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Press+Releases/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html <p><strong>Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growth</strong></p><p align="justify">TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue’s U.S. commercialization strategy, with a focus on expanding its existing presence in 38 http://www.streetinsider.com/Press+Releases/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html Wed, 21 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html <p><strong>Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growth</strong></p><p align="justify">TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue’s U.S. commercialization strategy, with a focus on expanding its existing presence in 38 http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html Wed, 21 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html <p><strong>Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growth</strong></p><p align="justify">TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue’s U.S. commercialization strategy, with a focus on expanding its existing presence in 38 http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html Wed, 21 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html <p><strong>Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growth</strong></p><p align="justify">TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue’s U.S. commercialization strategy, with a focus on expanding its existing presence in 38 http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Appoints+Industry+Veteran+Marc+Waldman+as+Vice+President%2C+Commercial/25871707.html Wed, 21 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Press+Releases/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html <p><strong>New Product Line Enhances Continuity of Care Across Clinical and Home Settings</strong></p><p>TYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ckpEnZ5Z5DbJ8G5tUdKCQmv8MaNwAz2qlDp-u8ff81h23DgQQ2ZMnW9m3ScFClfh4l-LMmY2CTu10oCSXP-jI5QPCnjw9nEl38-SyS3iidM=" rel="nofollow" target="_blank">ENvue Medical, Inc.</a> (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a line of over-the-counter ENFit Syringes designed to meet both feeding and medication delivery clinical needs.</p> <p align="justify">“As care continues to shift beyond the hospital setting, providers and caregivers need reliable, high-quality solutions that support patients http://www.streetinsider.com/Press+Releases/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html Wed, 14 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Press+Releases/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html <p><strong>New Product Line Enhances Continuity of Care Across Clinical and Home Settings</strong></p><p>TYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ckpEnZ5Z5DbJ8G5tUdKCQmv8MaNwAz2qlDp-u8ff81h23DgQQ2ZMnW9m3ScFClfh4l-LMmY2CTu10oCSXP-jI5QPCnjw9nEl38-SyS3iidM=" rel="nofollow" target="_blank">ENvue Medical, Inc.</a> (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a line of over-the-counter ENFit Syringes designed to meet both feeding and medication delivery clinical needs.</p> <p align="justify">“As care continues to shift beyond the hospital setting, providers and caregivers need reliable, high-quality solutions that support patients http://www.streetinsider.com/Press+Releases/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html Wed, 14 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Press+Releases/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html <p><strong>New Product Line Enhances Continuity of Care Across Clinical and Home Settings</strong></p><p>TYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ckpEnZ5Z5DbJ8G5tUdKCQmv8MaNwAz2qlDp-u8ff81h23DgQQ2ZMnW9m3ScFClfh4l-LMmY2CTu10oCSXP-jI5QPCnjw9nEl38-SyS3iidM=" rel="nofollow" target="_blank">ENvue Medical, Inc.</a> (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a line of over-the-counter ENFit Syringes designed to meet both feeding and medication delivery clinical needs.</p> <p align="justify">“As care continues to shift beyond the hospital setting, providers and caregivers need reliable, high-quality solutions that support patients http://www.streetinsider.com/Press+Releases/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html Wed, 14 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html <p><strong>New Product Line Enhances Continuity of Care Across Clinical and Home Settings</strong></p><p>TYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ckpEnZ5Z5DbJ8G5tUdKCQmv8MaNwAz2qlDp-u8ff81h23DgQQ2ZMnW9m3ScFClfh4l-LMmY2CTu10oCSXP-jI5QPCnjw9nEl38-SyS3iidM=" rel="nofollow" target="_blank">ENvue Medical, Inc.</a> (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a line of over-the-counter ENFit Syringes designed to meet both feeding and medication delivery clinical needs.</p> <p align="justify">“As care continues to shift beyond the hospital setting, providers and caregivers need reliable, high-quality solutions that support patients http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html Wed, 14 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html <p><strong>New Product Line Enhances Continuity of Care Across Clinical and Home Settings</strong></p><p>TYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ckpEnZ5Z5DbJ8G5tUdKCQmv8MaNwAz2qlDp-u8ff81h23DgQQ2ZMnW9m3ScFClfh4l-LMmY2CTu10oCSXP-jI5QPCnjw9nEl38-SyS3iidM=" rel="nofollow" target="_blank">ENvue Medical, Inc.</a> (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a line of over-the-counter ENFit Syringes designed to meet both feeding and medication delivery clinical needs.</p> <p align="justify">“As care continues to shift beyond the hospital setting, providers and caregivers need reliable, high-quality solutions that support patients http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html Wed, 14 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html <p><strong>New Product Line Enhances Continuity of Care Across Clinical and Home Settings</strong></p><p>TYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ckpEnZ5Z5DbJ8G5tUdKCQmv8MaNwAz2qlDp-u8ff81h23DgQQ2ZMnW9m3ScFClfh4l-LMmY2CTu10oCSXP-jI5QPCnjw9nEl38-SyS3iidM=" rel="nofollow" target="_blank">ENvue Medical, Inc.</a> (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a line of over-the-counter ENFit Syringes designed to meet both feeding and medication delivery clinical needs.</p> <p align="justify">“As care continues to shift beyond the hospital setting, providers and caregivers need reliable, high-quality solutions that support patients http://www.streetinsider.com/Globe+Newswire/ENvue+Medical+Launches+Over-the-Counter+Reusable+ENFit+Syringes+to+Support+Feeding+and+Medication+Delivery+without+a+Prescription/25847130.html Wed, 14 Jan 2026 08:30:00 -0500 FEED FEED NAOV http://www.streetinsider.com/Corporate+News/ENvue+Medical+launches+program+to+reduce+nasogastric+tube+discomfort/25829662.html <p>ENvue Medical Inc. (NASDAQ: FEED) announced the launch of a development program aimed at addressing patient pain and discomfort associated with indwelling nasogastric tubes. The medical technology company will integrate vibration-based technology from its NanoVibronix division to improve patient comfort during extended tube use.</p><p>The program builds on previously published, peer-reviewed clinical research demonstrating that surface acoustic wave micro-vibration technology applied to nasogastric tubes can reduce friction at the tube-tissue interface during indwelling use. Nasogastric tubes are widely used in hospital care and often remain in place for extended periods, commonly causing nasal and throat discomfort with limited current mitigation options.</p><p>"We http://www.streetinsider.com/Corporate+News/ENvue+Medical+launches+program+to+reduce+nasogastric+tube+discomfort/25829662.html Fri, 09 Jan 2026 09:02:39 -0500 FEED NAOV http://www.streetinsider.com/Corporate+News/ENvue+Medical+launches+program+to+reduce+nasogastric+tube+discomfort/25829662.html <p>ENvue Medical Inc. (NASDAQ: FEED) announced the launch of a development program aimed at addressing patient pain and discomfort associated with indwelling nasogastric tubes. The medical technology company will integrate vibration-based technology from its NanoVibronix division to improve patient comfort during extended tube use.</p><p>The program builds on previously published, peer-reviewed clinical research demonstrating that surface acoustic wave micro-vibration technology applied to nasogastric tubes can reduce friction at the tube-tissue interface during indwelling use. Nasogastric tubes are widely used in hospital care and often remain in place for extended periods, commonly causing nasal and throat discomfort with limited current mitigation options.</p><p>"We http://www.streetinsider.com/Corporate+News/ENvue+Medical+launches+program+to+reduce+nasogastric+tube+discomfort/25829662.html Fri, 09 Jan 2026 09:02:39 -0500 FEED NAOV http://www.streetinsider.com/Press+Releases/ENvue+Medical+Launches+Program+to+Address+Patient+Pain+and+Discomfort+with+Indwelling+Nasogastric+Tubes+Based+on+Previously+Published%2C+Peer-Reviewed+Clinical+Research/25829639.html <p><strong>The program will integrate the Company’s clinically validated NanoVibronix technology to improve comfort associated with indwelling nasogastric tubes</strong></p><p align="justify">TYLER, Texas, Jan. 09, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company”), a medical technology company specializing on the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the launch of a new development and integration program leveraging vibration-based technology from its NanoVibronix division to address pain and discomfort associated with indwelling nasogastric (NG) tubes.</p> <p align="justify">Nasogastric tubes are among the most widely http://www.streetinsider.com/Press+Releases/ENvue+Medical+Launches+Program+to+Address+Patient+Pain+and+Discomfort+with+Indwelling+Nasogastric+Tubes+Based+on+Previously+Published%2C+Peer-Reviewed+Clinical+Research/25829639.html Fri, 09 Jan 2026 09:01:00 -0500 FEED FEED NAOV